nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C18—Omeprazole—Barrett's esophagus	0.319	0.396	CbGbCtD
Cyclophosphamide—CYP2C19—Esomeprazole—Barrett's esophagus	0.109	0.135	CbGbCtD
Cyclophosphamide—CYP2C8—Omeprazole—Barrett's esophagus	0.0764	0.0949	CbGbCtD
Cyclophosphamide—CYP2C19—Omeprazole—Barrett's esophagus	0.0641	0.0796	CbGbCtD
Cyclophosphamide—CYP2C9—Omeprazole—Barrett's esophagus	0.0533	0.0662	CbGbCtD
Cyclophosphamide—CYP3A4—Esomeprazole—Barrett's esophagus	0.0526	0.0653	CbGbCtD
Cyclophosphamide—ABCB1—Omeprazole—Barrett's esophagus	0.0517	0.0642	CbGbCtD
Cyclophosphamide—CYP2D6—Omeprazole—Barrett's esophagus	0.0487	0.0605	CbGbCtD
Cyclophosphamide—CYP3A4—Omeprazole—Barrett's esophagus	0.031	0.0385	CbGbCtD
Cyclophosphamide—Hepatic encephalopathy—Omeprazole—Barrett's esophagus	0.0102	0.0592	CcSEcCtD
Cyclophosphamide—Hepatic encephalopathy—Esomeprazole—Barrett's esophagus	0.0102	0.0592	CcSEcCtD
Cyclophosphamide—Dysaesthesia—Esomeprazole—Barrett's esophagus	0.00342	0.0198	CcSEcCtD
Cyclophosphamide—Dysaesthesia—Omeprazole—Barrett's esophagus	0.00342	0.0198	CcSEcCtD
Cyclophosphamide—Encephalopathy—Esomeprazole—Barrett's esophagus	0.00231	0.0134	CcSEcCtD
Cyclophosphamide—Encephalopathy—Omeprazole—Barrett's esophagus	0.00231	0.0134	CcSEcCtD
Cyclophosphamide—Parosmia—Omeprazole—Barrett's esophagus	0.00228	0.0132	CcSEcCtD
Cyclophosphamide—Parosmia—Esomeprazole—Barrett's esophagus	0.00228	0.0132	CcSEcCtD
Cyclophosphamide—Necrosis—Esomeprazole—Barrett's esophagus	0.00189	0.0109	CcSEcCtD
Cyclophosphamide—Necrosis—Omeprazole—Barrett's esophagus	0.00189	0.0109	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.00163	0.00944	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.00163	0.00944	CcSEcCtD
Cyclophosphamide—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.0016	0.00925	CcSEcCtD
Cyclophosphamide—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.0016	0.00925	CcSEcCtD
Cyclophosphamide—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.00157	0.00907	CcSEcCtD
Cyclophosphamide—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.00157	0.00907	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00151	0.00874	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00151	0.00874	CcSEcCtD
Cyclophosphamide—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00145	0.00838	CcSEcCtD
Cyclophosphamide—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00145	0.00838	CcSEcCtD
Cyclophosphamide—Cystitis—Omeprazole—Barrett's esophagus	0.00143	0.00829	CcSEcCtD
Cyclophosphamide—Cystitis—Esomeprazole—Barrett's esophagus	0.00143	0.00829	CcSEcCtD
Cyclophosphamide—Fluid retention—Esomeprazole—Barrett's esophagus	0.00141	0.00815	CcSEcCtD
Cyclophosphamide—Fluid retention—Omeprazole—Barrett's esophagus	0.00141	0.00815	CcSEcCtD
Cyclophosphamide—Neoplasm—Omeprazole—Barrett's esophagus	0.00134	0.00776	CcSEcCtD
Cyclophosphamide—Bladder pain—Omeprazole—Barrett's esophagus	0.00134	0.00776	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00134	0.00776	CcSEcCtD
Cyclophosphamide—Bladder pain—Esomeprazole—Barrett's esophagus	0.00134	0.00776	CcSEcCtD
Cyclophosphamide—Neoplasm—Esomeprazole—Barrett's esophagus	0.00134	0.00776	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00134	0.00776	CcSEcCtD
Cyclophosphamide—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00123	0.00713	CcSEcCtD
Cyclophosphamide—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00123	0.00713	CcSEcCtD
Cyclophosphamide—Polyuria—Esomeprazole—Barrett's esophagus	0.00122	0.0071	CcSEcCtD
Cyclophosphamide—Polyuria—Omeprazole—Barrett's esophagus	0.00122	0.0071	CcSEcCtD
Cyclophosphamide—Swelling—Esomeprazole—Barrett's esophagus	0.00122	0.00706	CcSEcCtD
Cyclophosphamide—Swelling—Omeprazole—Barrett's esophagus	0.00122	0.00706	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00121	0.00703	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00121	0.00703	CcSEcCtD
Cyclophosphamide—Hepatic failure—Omeprazole—Barrett's esophagus	0.0012	0.00693	CcSEcCtD
Cyclophosphamide—Hepatic failure—Esomeprazole—Barrett's esophagus	0.0012	0.00693	CcSEcCtD
Cyclophosphamide—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00119	0.0069	CcSEcCtD
Cyclophosphamide—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00119	0.0069	CcSEcCtD
Cyclophosphamide—Hot flush—Esomeprazole—Barrett's esophagus	0.00115	0.00666	CcSEcCtD
Cyclophosphamide—Hot flush—Omeprazole—Barrett's esophagus	0.00115	0.00666	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00114	0.0066	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00114	0.0066	CcSEcCtD
Cyclophosphamide—Renal impairment—Omeprazole—Barrett's esophagus	0.00113	0.00655	CcSEcCtD
Cyclophosphamide—Renal impairment—Esomeprazole—Barrett's esophagus	0.00113	0.00655	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00108	0.00626	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00108	0.00626	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00108	0.00623	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00108	0.00623	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000968	0.00561	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000968	0.00561	CcSEcCtD
Cyclophosphamide—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000914	0.0053	CcSEcCtD
Cyclophosphamide—Bronchospasm—Omeprazole—Barrett's esophagus	0.000914	0.0053	CcSEcCtD
Cyclophosphamide—Sweating increased—Omeprazole—Barrett's esophagus	0.000905	0.00525	CcSEcCtD
Cyclophosphamide—Sweating increased—Esomeprazole—Barrett's esophagus	0.000905	0.00525	CcSEcCtD
Cyclophosphamide—Pancytopenia—Omeprazole—Barrett's esophagus	0.000882	0.00511	CcSEcCtD
Cyclophosphamide—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000882	0.00511	CcSEcCtD
Cyclophosphamide—Weight increased—Omeprazole—Barrett's esophagus	0.000846	0.0049	CcSEcCtD
Cyclophosphamide—Weight increased—Esomeprazole—Barrett's esophagus	0.000846	0.0049	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000821	0.00476	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000821	0.00476	CcSEcCtD
Cyclophosphamide—Renal failure—Esomeprazole—Barrett's esophagus	0.000814	0.00472	CcSEcCtD
Cyclophosphamide—Renal failure—Omeprazole—Barrett's esophagus	0.000814	0.00472	CcSEcCtD
Cyclophosphamide—Jaundice—Esomeprazole—Barrett's esophagus	0.000808	0.00468	CcSEcCtD
Cyclophosphamide—Stomatitis—Omeprazole—Barrett's esophagus	0.000808	0.00468	CcSEcCtD
Cyclophosphamide—Jaundice—Omeprazole—Barrett's esophagus	0.000808	0.00468	CcSEcCtD
Cyclophosphamide—Stomatitis—Esomeprazole—Barrett's esophagus	0.000808	0.00468	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000805	0.00467	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000805	0.00467	CcSEcCtD
Cyclophosphamide—Haematuria—Esomeprazole—Barrett's esophagus	0.00079	0.00458	CcSEcCtD
Cyclophosphamide—Haematuria—Omeprazole—Barrett's esophagus	0.00079	0.00458	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000773	0.00448	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000773	0.00448	CcSEcCtD
Cyclophosphamide—Bradycardia—Omeprazole—Barrett's esophagus	0.000757	0.00439	CcSEcCtD
Cyclophosphamide—Bradycardia—Esomeprazole—Barrett's esophagus	0.000757	0.00439	CcSEcCtD
Cyclophosphamide—Rhinitis—Omeprazole—Barrett's esophagus	0.000746	0.00432	CcSEcCtD
Cyclophosphamide—Rhinitis—Esomeprazole—Barrett's esophagus	0.000746	0.00432	CcSEcCtD
Cyclophosphamide—Hepatitis—Omeprazole—Barrett's esophagus	0.000744	0.00431	CcSEcCtD
Cyclophosphamide—Hepatitis—Esomeprazole—Barrett's esophagus	0.000744	0.00431	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00074	0.00429	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00074	0.00429	CcSEcCtD
Cyclophosphamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00073	0.0327	CbGpPWpGaD
Cyclophosphamide—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000726	0.0325	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00072	0.0323	CbGpPWpGaD
Cyclophosphamide—Visual impairment—Omeprazole—Barrett's esophagus	0.000717	0.00415	CcSEcCtD
Cyclophosphamide—Visual impairment—Esomeprazole—Barrett's esophagus	0.000717	0.00415	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000703	0.00408	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000703	0.00408	CcSEcCtD
Cyclophosphamide—Tinnitus—Esomeprazole—Barrett's esophagus	0.000693	0.00402	CcSEcCtD
Cyclophosphamide—Tinnitus—Omeprazole—Barrett's esophagus	0.000693	0.00402	CcSEcCtD
Cyclophosphamide—Flushing—Esomeprazole—Barrett's esophagus	0.00069	0.004	CcSEcCtD
Cyclophosphamide—Flushing—Omeprazole—Barrett's esophagus	0.00069	0.004	CcSEcCtD
Cyclophosphamide—Chills—Esomeprazole—Barrett's esophagus	0.000667	0.00387	CcSEcCtD
Cyclophosphamide—Chills—Omeprazole—Barrett's esophagus	0.000667	0.00387	CcSEcCtD
Cyclophosphamide—Alopecia—Esomeprazole—Barrett's esophagus	0.000657	0.00381	CcSEcCtD
Cyclophosphamide—Alopecia—Omeprazole—Barrett's esophagus	0.000657	0.00381	CcSEcCtD
Cyclophosphamide—Dysgeusia—Omeprazole—Barrett's esophagus	0.000634	0.00367	CcSEcCtD
Cyclophosphamide—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000634	0.00367	CcSEcCtD
Cyclophosphamide—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000623	0.00361	CcSEcCtD
Cyclophosphamide—Muscle spasms—Omeprazole—Barrett's esophagus	0.000623	0.00361	CcSEcCtD
Cyclophosphamide—Vision blurred—Esomeprazole—Barrett's esophagus	0.00061	0.00354	CcSEcCtD
Cyclophosphamide—Vision blurred—Omeprazole—Barrett's esophagus	0.00061	0.00354	CcSEcCtD
Cyclophosphamide—Tremor—Esomeprazole—Barrett's esophagus	0.000607	0.00352	CcSEcCtD
Cyclophosphamide—Tremor—Omeprazole—Barrett's esophagus	0.000607	0.00352	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000601	0.00348	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000601	0.00348	CcSEcCtD
Cyclophosphamide—Anaemia—Esomeprazole—Barrett's esophagus	0.000598	0.00347	CcSEcCtD
Cyclophosphamide—Anaemia—Omeprazole—Barrett's esophagus	0.000598	0.00347	CcSEcCtD
Cyclophosphamide—Agitation—Omeprazole—Barrett's esophagus	0.000595	0.00345	CcSEcCtD
Cyclophosphamide—Agitation—Esomeprazole—Barrett's esophagus	0.000595	0.00345	CcSEcCtD
Cyclophosphamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000592	0.0265	CbGpPWpGaD
Cyclophosphamide—Malaise—Esomeprazole—Barrett's esophagus	0.000584	0.00338	CcSEcCtD
Cyclophosphamide—Malaise—Omeprazole—Barrett's esophagus	0.000584	0.00338	CcSEcCtD
Cyclophosphamide—Leukopenia—Esomeprazole—Barrett's esophagus	0.00058	0.00336	CcSEcCtD
Cyclophosphamide—Leukopenia—Omeprazole—Barrett's esophagus	0.00058	0.00336	CcSEcCtD
Cyclophosphamide—Palpitations—Omeprazole—Barrett's esophagus	0.000572	0.00332	CcSEcCtD
Cyclophosphamide—Palpitations—Esomeprazole—Barrett's esophagus	0.000572	0.00332	CcSEcCtD
Cyclophosphamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000565	0.0253	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000565	0.0253	CbGpPWpGaD
Cyclophosphamide—Cough—Omeprazole—Barrett's esophagus	0.000565	0.00327	CcSEcCtD
Cyclophosphamide—Cough—Esomeprazole—Barrett's esophagus	0.000565	0.00327	CcSEcCtD
Cyclophosphamide—Hypertension—Esomeprazole—Barrett's esophagus	0.000559	0.00324	CcSEcCtD
Cyclophosphamide—Hypertension—Omeprazole—Barrett's esophagus	0.000559	0.00324	CcSEcCtD
Cyclophosphamide—Chest pain—Omeprazole—Barrett's esophagus	0.000551	0.00319	CcSEcCtD
Cyclophosphamide—Myalgia—Esomeprazole—Barrett's esophagus	0.000551	0.00319	CcSEcCtD
Cyclophosphamide—Chest pain—Esomeprazole—Barrett's esophagus	0.000551	0.00319	CcSEcCtD
Cyclophosphamide—Arthralgia—Esomeprazole—Barrett's esophagus	0.000551	0.00319	CcSEcCtD
Cyclophosphamide—Arthralgia—Omeprazole—Barrett's esophagus	0.000551	0.00319	CcSEcCtD
Cyclophosphamide—Myalgia—Omeprazole—Barrett's esophagus	0.000551	0.00319	CcSEcCtD
Cyclophosphamide—Discomfort—Esomeprazole—Barrett's esophagus	0.000545	0.00316	CcSEcCtD
Cyclophosphamide—Discomfort—Omeprazole—Barrett's esophagus	0.000545	0.00316	CcSEcCtD
Cyclophosphamide—Confusional state—Esomeprazole—Barrett's esophagus	0.000533	0.00309	CcSEcCtD
Cyclophosphamide—Confusional state—Omeprazole—Barrett's esophagus	0.000533	0.00309	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000528	0.00306	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000528	0.00306	CcSEcCtD
Cyclophosphamide—Infection—Omeprazole—Barrett's esophagus	0.000525	0.00304	CcSEcCtD
Cyclophosphamide—Infection—Esomeprazole—Barrett's esophagus	0.000525	0.00304	CcSEcCtD
Cyclophosphamide—Shock—Esomeprazole—Barrett's esophagus	0.00052	0.00301	CcSEcCtD
Cyclophosphamide—Shock—Omeprazole—Barrett's esophagus	0.00052	0.00301	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000517	0.003	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000517	0.003	CcSEcCtD
Cyclophosphamide—Tachycardia—Esomeprazole—Barrett's esophagus	0.000516	0.00299	CcSEcCtD
Cyclophosphamide—Tachycardia—Omeprazole—Barrett's esophagus	0.000516	0.00299	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000511	0.00296	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000511	0.00296	CcSEcCtD
Cyclophosphamide—Anorexia—Esomeprazole—Barrett's esophagus	0.000504	0.00292	CcSEcCtD
Cyclophosphamide—Anorexia—Omeprazole—Barrett's esophagus	0.000504	0.00292	CcSEcCtD
Cyclophosphamide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000485	0.0217	CbGpPWpGaD
Cyclophosphamide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000481	0.00279	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000481	0.00279	CcSEcCtD
Cyclophosphamide—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000479	0.0215	CbGpPWpGaD
Cyclophosphamide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000475	0.00275	CcSEcCtD
Cyclophosphamide—Paraesthesia—Omeprazole—Barrett's esophagus	0.000475	0.00275	CcSEcCtD
Cyclophosphamide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000471	0.00273	CcSEcCtD
Cyclophosphamide—Dyspnoea—Omeprazole—Barrett's esophagus	0.000471	0.00273	CcSEcCtD
Cyclophosphamide—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000464	0.0208	CbGpPWpGaD
Cyclophosphamide—Decreased appetite—Omeprazole—Barrett's esophagus	0.000459	0.00266	CcSEcCtD
Cyclophosphamide—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000459	0.00266	CcSEcCtD
Cyclophosphamide—Fatigue—Esomeprazole—Barrett's esophagus	0.000456	0.00264	CcSEcCtD
Cyclophosphamide—Fatigue—Omeprazole—Barrett's esophagus	0.000456	0.00264	CcSEcCtD
Cyclophosphamide—Constipation—Omeprazole—Barrett's esophagus	0.000452	0.00262	CcSEcCtD
Cyclophosphamide—Pain—Omeprazole—Barrett's esophagus	0.000452	0.00262	CcSEcCtD
Cyclophosphamide—Constipation—Esomeprazole—Barrett's esophagus	0.000452	0.00262	CcSEcCtD
Cyclophosphamide—Pain—Esomeprazole—Barrett's esophagus	0.000452	0.00262	CcSEcCtD
Cyclophosphamide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000447	0.02	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000445	0.0199	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000439	0.0197	CbGpPWpGaD
Cyclophosphamide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000435	0.00252	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000435	0.00252	CcSEcCtD
Cyclophosphamide—Urticaria—Omeprazole—Barrett's esophagus	0.00042	0.00243	CcSEcCtD
Cyclophosphamide—Urticaria—Esomeprazole—Barrett's esophagus	0.00042	0.00243	CcSEcCtD
Cyclophosphamide—Body temperature increased—Omeprazole—Barrett's esophagus	0.000418	0.00242	CcSEcCtD
Cyclophosphamide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000418	0.00242	CcSEcCtD
Cyclophosphamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000417	0.0187	CbGpPWpGaD
Cyclophosphamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000417	0.0187	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000414	0.0185	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000393	0.0176	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00039	0.0174	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00039	0.0174	CbGpPWpGaD
Cyclophosphamide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000389	0.00226	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000389	0.00226	CcSEcCtD
Cyclophosphamide—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000383	0.0172	CbGpPWpGaD
Cyclophosphamide—Asthenia—Esomeprazole—Barrett's esophagus	0.000379	0.0022	CcSEcCtD
Cyclophosphamide—Asthenia—Omeprazole—Barrett's esophagus	0.000379	0.0022	CcSEcCtD
Cyclophosphamide—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000378	0.0169	CbGpPWpGaD
Cyclophosphamide—Pruritus—Omeprazole—Barrett's esophagus	0.000374	0.00217	CcSEcCtD
Cyclophosphamide—Pruritus—Esomeprazole—Barrett's esophagus	0.000374	0.00217	CcSEcCtD
Cyclophosphamide—Diarrhoea—Omeprazole—Barrett's esophagus	0.000362	0.0021	CcSEcCtD
Cyclophosphamide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000362	0.0021	CcSEcCtD
Cyclophosphamide—CYP2A6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000361	0.0162	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000359	0.0161	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000354	0.0159	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000351	0.0157	CbGpPWpGaD
Cyclophosphamide—Dizziness—Esomeprazole—Barrett's esophagus	0.000349	0.00202	CcSEcCtD
Cyclophosphamide—Dizziness—Omeprazole—Barrett's esophagus	0.000349	0.00202	CcSEcCtD
Cyclophosphamide—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000346	0.0155	CbGpPWpGaD
Cyclophosphamide—Vomiting—Omeprazole—Barrett's esophagus	0.000336	0.00195	CcSEcCtD
Cyclophosphamide—Vomiting—Esomeprazole—Barrett's esophagus	0.000336	0.00195	CcSEcCtD
Cyclophosphamide—Rash—Esomeprazole—Barrett's esophagus	0.000333	0.00193	CcSEcCtD
Cyclophosphamide—Rash—Omeprazole—Barrett's esophagus	0.000333	0.00193	CcSEcCtD
Cyclophosphamide—Dermatitis—Omeprazole—Barrett's esophagus	0.000333	0.00193	CcSEcCtD
Cyclophosphamide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000333	0.00193	CcSEcCtD
Cyclophosphamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.000331	0.0148	CbGpPWpGaD
Cyclophosphamide—Headache—Omeprazole—Barrett's esophagus	0.000331	0.00192	CcSEcCtD
Cyclophosphamide—Headache—Esomeprazole—Barrett's esophagus	0.000331	0.00192	CcSEcCtD
Cyclophosphamide—CYP2C18—Biological oxidations—CYP26A1—Barrett's esophagus	0.000314	0.0141	CbGpPWpGaD
Cyclophosphamide—Nausea—Omeprazole—Barrett's esophagus	0.000314	0.00182	CcSEcCtD
Cyclophosphamide—Nausea—Esomeprazole—Barrett's esophagus	0.000314	0.00182	CcSEcCtD
Cyclophosphamide—CYP2C18—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00031	0.0139	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000304	0.0136	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.0003	0.0134	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000291	0.013	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000284	0.0127	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000271	0.0121	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000268	0.012	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000268	0.012	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000257	0.0115	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000257	0.0115	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000249	0.0112	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000247	0.0111	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000246	0.011	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000246	0.011	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000244	0.0109	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00022	0.00985	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000209	0.00936	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000206	0.00923	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000202	0.00906	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.0002	0.00898	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000192	0.00858	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000186	0.00833	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000178	0.00798	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000163	0.00731	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000161	0.00721	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000155	0.00692	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000152	0.00683	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000151	0.00677	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000149	0.00667	CbGpPWpGaD
Cyclophosphamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000137	0.00615	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000132	0.00592	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000131	0.00586	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000129	0.00578	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000128	0.00574	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000117	0.00523	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000115	0.00516	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000111	0.00495	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000107	0.00481	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000106	0.00477	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000106	0.00475	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000105	0.0047	CbGpPWpGaD
Cyclophosphamide—CYP2A6—NRF2 pathway—HGF—Barrett's esophagus	0.0001	0.00449	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.1e-05	0.00408	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	8.45e-05	0.00379	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.12e-05	0.00364	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.41e-05	0.00332	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGES—Barrett's esophagus	7.09e-05	0.00318	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	7.02e-05	0.00315	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.93e-05	0.0031	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.63e-05	0.00297	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.92e-05	0.00265	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.4e-05	0.00242	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP26A1—Barrett's esophagus	5.38e-05	0.00241	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	5.33e-05	0.00239	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	4.9e-05	0.00219	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGES—Barrett's esophagus	4.72e-05	0.00211	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGES—Barrett's esophagus	4.32e-05	0.00194	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—SLC9A1—Barrett's esophagus	3.88e-05	0.00174	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	3.57e-05	0.0016	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	3.57e-05	0.0016	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGES—Barrett's esophagus	3.49e-05	0.00156	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.41e-05	0.00153	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP26A1—Barrett's esophagus	3.28e-05	0.00147	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3e-05	0.00134	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGES—Barrett's esophagus	2.95e-05	0.00132	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	2.71e-05	0.00122	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	2.64e-05	0.00118	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGES—Barrett's esophagus	2.64e-05	0.00118	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	2.58e-05	0.00116	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	2.58e-05	0.00115	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.57e-05	0.00115	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.42e-05	0.00109	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.4e-05	0.00108	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—SLC9A1—Barrett's esophagus	2.36e-05	0.00106	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.24e-05	0.001	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2e-05	0.000895	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	1.95e-05	0.000873	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	1.91e-05	0.000853	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	1.86e-05	0.000834	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	1.84e-05	0.000823	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.82e-05	0.000816	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PPARG—Barrett's esophagus	1.77e-05	0.000792	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.65e-05	0.000741	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.62e-05	0.000723	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.61e-05	0.000723	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.58e-05	0.00071	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.48e-05	0.000661	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.44e-05	0.000645	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.41e-05	0.000629	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—Barrett's esophagus	1.39e-05	0.000623	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.35e-05	0.000603	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.32e-05	0.000593	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.31e-05	0.000588	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.3e-05	0.000583	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.2e-05	0.000538	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.18e-05	0.000527	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.16e-05	0.00052	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—Barrett's esophagus	1.08e-05	0.000483	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.06e-05	0.000474	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	9.25e-06	0.000414	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—Barrett's esophagus	8.7e-06	0.00039	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	8.66e-06	0.000388	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—Barrett's esophagus	8.5e-06	0.000381	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—Barrett's esophagus	8.48e-06	0.00038	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—Barrett's esophagus	7.36e-06	0.00033	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	6.84e-06	0.000306	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	6.69e-06	0.0003	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—Barrett's esophagus	6.57e-06	0.000294	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—Barrett's esophagus	6.41e-06	0.000287	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.04e-06	0.000271	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—Barrett's esophagus	5.99e-06	0.000268	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	5.79e-06	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	5.17e-06	0.000232	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—Barrett's esophagus	5.05e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	4.76e-06	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	4.71e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—Barrett's esophagus	3.95e-06	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.11e-06	0.000139	CbGpPWpGaD
